Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

CKLF-Like MARVEL Transmembrane Domain Containing 2 (CMTM2) Peptide

CMTM2 Reactivity: Mammalian Host: Synthetic BP, WB, IHC
Catalog No. ABIN937415

Quick Overview for CKLF-Like MARVEL Transmembrane Domain Containing 2 (CMTM2) Peptide (ABIN937415)

Target

CMTM2 (CKLF-Like MARVEL Transmembrane Domain Containing 2 (CMTM2))

Origin

Mammalian

Source

  • 1
Synthetic

Application

Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
  • Peptide Type

    Synthetic

    Sequence

    DKPQKAVQDH KEPSDKPQKA VQPKHEVGTR RGCRRYRWEL KDSNKEFWLL

    Characteristics

    A synthetic peptide for use as a blocking control in assays to test for specificity of CMTM2 antibody,
    Alternative Names: CMTM2 control peptide, CMTM2 antibody Blocking Peptide, Anti-CMTM2 Blocking Peptide, Cklf-Like Marvel Transmembrane Domain Containing 2 Blocking Peptide, CKLFSF2 Blocking Peptide, MGC39436 Blocking Peptide
  • Application Notes

    Optimal conditions should be determined by the investigator

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.

    Buffer

    PBS

    Handling Advice

    Avoid repeated freeze/thaw cycles.

    Storage

    -20 °C

    Storage Comment

    Store at -20 °C long term.
  • Target

    CMTM2 (CKLF-Like MARVEL Transmembrane Domain Containing 2 (CMTM2))

    Background

    CMTM2 belongs to the chemokine-like factor superfamily, a novel family that links the chemokine and the transmembrane 4 superfamilies of signaling molecules. The protein may play an important role in testicular development. This gene belongs to the chemokine-like factor geneuperfamily, a novel family that links the chemokine and the transmembrane 4 superfamilies of signaling molecules. The protein encoded by this gene may play an important role in testicular development.

    Molecular Weight

    27 kDa
You are here:
Chat with us!